Cargando…
Treatable Cause of Refractory Seizures in an Infant with a Novel Mutation
Pyridoxine-dependent epilepsy is a treatable cause of epilepsy, which is very well known. It is most commonly caused by mutations in ALDH7A1 and PNPO genes. A 5-month-old infant presented with refractory seizures. Magnetic resonance imaging (MRI) brain was normal. Clinical exome sequencing showed a...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276961/ https://www.ncbi.nlm.nih.gov/pubmed/34316313 http://dx.doi.org/10.4103/jpn.JPN_68_20 |
_version_ | 1783721988381999104 |
---|---|
author | Mittal, Ruchi R. Manokaran, Ranjith Kumar James, Saji |
author_facet | Mittal, Ruchi R. Manokaran, Ranjith Kumar James, Saji |
author_sort | Mittal, Ruchi R. |
collection | PubMed |
description | Pyridoxine-dependent epilepsy is a treatable cause of epilepsy, which is very well known. It is most commonly caused by mutations in ALDH7A1 and PNPO genes. A 5-month-old infant presented with refractory seizures. Magnetic resonance imaging (MRI) brain was normal. Clinical exome sequencing showed a novel mutation in PROSC gene. He responded very well to pyridoxine and has been seizure free since the beginning of the treatment. PROSC gene mutations have been recently described as a cause for pyridoxine-dependent epilepsy. Here, we describe a first case report of PROSC mutation from India with a rare genetic variant presenting as pyridoxine-dependent epilepsy. |
format | Online Article Text |
id | pubmed-8276961 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-82769612021-07-26 Treatable Cause of Refractory Seizures in an Infant with a Novel Mutation Mittal, Ruchi R. Manokaran, Ranjith Kumar James, Saji J Pediatr Neurosci Case Reports Pyridoxine-dependent epilepsy is a treatable cause of epilepsy, which is very well known. It is most commonly caused by mutations in ALDH7A1 and PNPO genes. A 5-month-old infant presented with refractory seizures. Magnetic resonance imaging (MRI) brain was normal. Clinical exome sequencing showed a novel mutation in PROSC gene. He responded very well to pyridoxine and has been seizure free since the beginning of the treatment. PROSC gene mutations have been recently described as a cause for pyridoxine-dependent epilepsy. Here, we describe a first case report of PROSC mutation from India with a rare genetic variant presenting as pyridoxine-dependent epilepsy. Wolters Kluwer - Medknow 2021 2021-06-25 /pmc/articles/PMC8276961/ /pubmed/34316313 http://dx.doi.org/10.4103/jpn.JPN_68_20 Text en Copyright: © 2021 Journal of Pediatric Neurosciences https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Case Reports Mittal, Ruchi R. Manokaran, Ranjith Kumar James, Saji Treatable Cause of Refractory Seizures in an Infant with a Novel Mutation |
title | Treatable Cause of Refractory Seizures in an Infant with a Novel Mutation |
title_full | Treatable Cause of Refractory Seizures in an Infant with a Novel Mutation |
title_fullStr | Treatable Cause of Refractory Seizures in an Infant with a Novel Mutation |
title_full_unstemmed | Treatable Cause of Refractory Seizures in an Infant with a Novel Mutation |
title_short | Treatable Cause of Refractory Seizures in an Infant with a Novel Mutation |
title_sort | treatable cause of refractory seizures in an infant with a novel mutation |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276961/ https://www.ncbi.nlm.nih.gov/pubmed/34316313 http://dx.doi.org/10.4103/jpn.JPN_68_20 |
work_keys_str_mv | AT mittalruchir treatablecauseofrefractoryseizuresinaninfantwithanovelmutation AT manokaranranjithkumar treatablecauseofrefractoryseizuresinaninfantwithanovelmutation AT jamessaji treatablecauseofrefractoryseizuresinaninfantwithanovelmutation |